Search

everythinglearnresearchcommunity

for

Search:↓

Pediatric dermatologists have varied preferences for treating alopecia areata in children, with no standard FDA-approved treatments and some using JAK inhibitors despite risks.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

New vitiligo treatments focus on controlling immune damage and restoring skin color.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Local corticosteroids can help with alopecia areata, but hair loss often returns after stopping treatment.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Living with lupus as both a patient and doctor improved understanding and care for others.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

The document concludes that early diagnosis and treatment are key for pediatric hair loss disorders, and addressing the emotional effects on children is important.

The laser effectively removes hair for skin types IV and V but is less effective for type VI.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

The document concludes that different types of hair loss have specific treatments, and early diagnosis is crucial for preventing permanent hair loss.

Tildrakizumab may cause alopecia areata, but stopping it and using corticosteroids can regrow hair.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

The combination of oral PUVA and corticosteroids helps regrow hair in severe alopecia areata.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

No cure exists for alopecia areata, and treatments are personalized.

A 45-year-old woman with autoimmune diseases experienced patchy hair loss due to alopecia areata, which has no cure but can be treated, with varying success.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Korean Red Ginseng may help improve hair regrowth when used with corticosteroid injections for Alopecia Areata.

A woman with frontal fibrosing alopecia experienced unusual hair growth after using a specific topical lotion.

The study found that Keratosis Pilaris Atrophicans is a genetic skin condition that starts in childhood, involves inflammation and scarring, and current treatments are only somewhat effective.